Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // January 11th, 2012 // 8:07 am
• Pharma Blog » Archives
Johnson & Johnson
J&J Warned By FDA Over Remarks By Sales Rep
3 CommentsBy Ed Silverman // January 10th, 2012 // 8:33 am
The Novartis Recall And $560M In Lost Sales
6 CommentsBy Ed Silverman // January 10th, 2012 // 8:26 am
And The Outlook For Provenge Is… A Mixed Bag
Make a commentBy Ed Silverman // January 9th, 2012 // 10:22 am
Socially Responsible Investing, J&J And Levaquin
24 CommentsBy Ed Silverman // January 9th, 2012 // 8:48 am
Novartis Recalls OTC Meds Made At Troubled Plant
14 CommentsBy Ed Silverman // January 9th, 2012 // 8:02 am
Pharmalot… Pharmalittle… The Weekend Nears
Make a commentBy Ed Silverman // January 6th, 2012 // 8:08 am
J&J May Pay $1B To Make Risperdal Probe Go Away
5 CommentsBy Ed Silverman // January 5th, 2012 // 4:22 pm
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // January 5th, 2012 // 8:10 am